YatırımMasasıYatırım Masası home
Michaela Levin, Acrivon Therapeutics grant
Officer, SEC Form 4, filed on September 2, 2026
+30,000 sharesnet change in holding. Not an open-market purchase or sale
- Transaction date
- August 31, 2026
- Shares held after
- 30,000Direct ownership
- Change in holding
- Could not be calculatedFrom the transactions in the filing
- Filing rows
- 1None is a purchase or sale
Price context
ACRV daily close, Apr 27 to October 26, 2026$2.39$1.38
Daily close
Grants, options, tax
- Transaction price
- Not reportedNot an open-market trade
- Close on trade date
- $2.09August 31, 2026
- Latest close
- $1.72October 26, 2026
- Since the trade
- −17.70%vs the close on trade date
Transactions in the filing
DateTransactionSecuritySharesPriceAmountAfter
Grant
Common stockDirect
30,000
30,000
Recent filings at Acrivon Therapeutics
Full historyPersonTransactionAmount or sharesDate